Sargramostim (rhu GM-CSF) and Immune Checkpoint Inhibitors : Combinatorial Therapeutic Studies in Metastatic Melanoma(Post)
Metastatic melanoma presents significant treatment challenges, but advancements in immunotherapy, particularly the combination of Sargramostim (rhu GM-CSF) and immune checkpoint inhibitors, offer pr ...
Product results
Product results
- Product
- Qty in Cart
- Quantity
- Price
- Subtotal
-
Anti-PD-1 (PembrolizumAb) | Gentaur
Select Currency //340.00Anti-PD-1 (PembrolizumAb)26-A1306-100-GENSelect Currency //340.00 -
SHIKARI Q-PEM (Pembrolizumab) ELISA | 30137260
Select Currency //1,524.00SHIKARI Q-PEM (Pembrolizumab) ELISA | 30137260 | IBL International Application: ELISA Category Type: Immunology181-30137260Select Currency //1,524.00 -
SHIKARI S-ATP (Anti-Pembrolizumab Ab) ELISA | 30137262
Select Currency //1,524.00SHIKARI S-ATP (Anti-Pembrolizumab Ab) ELISA | 30137262 | IBL International Application: ELISA Category Type: Immunology181-30137262Select Currency //1,524.00 -
pHR_Gal4UAS_Pembrolizumab_heavychain_T2A_ Pembrolizumab_lightcha
Select Currency //266.00Order pHR_Gal4UAS_Pembrolizumab_heavychain_T2A_ Pembrolizumab_lightcha from Nova Lifetech / Life Science Market by email to eu@genprice.comPVT11019Select Currency //266.00